A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
Titel:
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
Auteur:
Patnaik, Amita LoRusso, Patricia M. Messersmith, Wells A. Papadopoulos, Kyriakos P. Gore, Lia Beeram, Muralidhar Ramakrishnan, Vanitha Kim, Amy H. Beyer, Joseph C. Mason Shih, L. Darbonne, Walter C. Xin, Yan Yu, Ron Xiang, Hong Brachmann, Rainer K. Weekes, Colin D.